Related Experiment Video
Updated: Feb 28, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.6K
[Delayed diagnosis of Huntington's disease in a psychiatric setting]
Tijdschrift Voor Psychiatrie
|June 15, 2017
Summary
Huntington's disease, a neurodegenerative disorder, often presents with psychiatric symptoms that can delay diagnosis. This study examines three cases where initial neuropsychiatric signs in Huntington's disease led to misdiagnosis and delayed treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder.
- It is characterized by a combination of motor, cognitive, and psychiatric symptoms.
- Early symptoms can be subtle and varied, complicating diagnosis.
Observation:
- The triad of symptoms includes motor disturbances, cognitive decline, and neuropsychiatric issues.
- Neuropsychiatric symptoms, such as depression or anxiety, may manifest before motor symptoms.
- Misinterpretation of initial psychiatric symptoms can lead to diagnostic delays.
Findings:
- Three case studies illustrate delayed diagnosis of Huntington's disease in psychiatric settings.
- Patients initially presented with neuropsychiatric symptoms that were mistaken for primary psychiatric disorders.
- The correct diagnosis of Huntington's disease was established after a significant delay.
Implications:
- Highlighting the importance of considering Huntington's disease in patients with unexplained neuropsychiatric symptoms.
- Emphasizes the need for comprehensive diagnostic evaluation in psychiatric patients.
- Suggests improved screening protocols for Huntington's disease in psychiatric care settings.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:28Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
01:28Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
01:17Schizophrenia
1.3K
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.3K